Herbalife Ltd. (NYSE:HLF) Receives Average Rating of “Hold” from Analysts

Shares of Herbalife Ltd. (NYSE:HLF) have earned an average recommendation of “Hold” from the five brokerages that are covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and two have issued a buy recommendation on the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is $9.90.

Several analysts have issued reports on HLF shares. Citigroup dropped their price objective on Herbalife from $16.00 to $13.00 and set a “buy” rating on the stock in a research note on Friday, October 25th. Mizuho increased their price target on Herbalife from $8.00 to $9.00 and gave the company a “neutral” rating in a research note on Friday, November 1st. B. Riley reduced their price objective on shares of Herbalife from $17.00 to $12.00 and set a “buy” rating for the company in a research report on Thursday, October 31st. DA Davidson dropped their price objective on shares of Herbalife from $13.00 to $7.50 and set a “neutral” rating on the stock in a research report on Thursday, October 31st. Finally, StockNews.com upgraded shares of Herbalife from a “hold” rating to a “buy” rating in a research note on Monday, November 4th.

Herbalife Trading Up 0.9 %

NYSE HLF opened at $6.74 on Tuesday. Herbalife has a 12 month low of $6.21 and a 12 month high of $14.39. The stock has a 50 day moving average of $7.57 and a 200-day moving average of $8.46. The company has a market cap of $679.34 million, a PE ratio of 7.93, a PEG ratio of 0.26 and a beta of 1.17.

Herbalife (NYSE:HLF) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $0.57 EPS for the quarter, beating analysts’ consensus estimates of $0.19 by $0.38. The firm had revenue of $1.24 billion during the quarter, compared to analysts’ expectations of $1.23 billion. Herbalife had a net margin of 1.73% and a negative return on equity of 18.66%. As a group, sell-side analysts predict that Herbalife will post 1.51 EPS for the current fiscal year.

Hedge Funds Weigh In On Herbalife

Several institutional investors and hedge funds have recently modified their holdings of HLF. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in shares of Herbalife by 72.1% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 168,209 shares of the company’s stock worth $1,209,000 after purchasing an additional 70,498 shares in the last quarter. Barclays PLC grew its position in Herbalife by 347.0% during the third quarter. Barclays PLC now owns 161,426 shares of the company’s stock worth $1,160,000 after buying an additional 125,311 shares in the last quarter. Charles Schwab Investment Management Inc. increased its stake in Herbalife by 6.9% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 2,479,957 shares of the company’s stock worth $17,831,000 after acquiring an additional 160,792 shares during the period. Baupost Group LLC MA raised its holdings in Herbalife by 128.3% in the 2nd quarter. Baupost Group LLC MA now owns 5,124,526 shares of the company’s stock valued at $53,244,000 after acquiring an additional 2,879,603 shares in the last quarter. Finally, Marshall Wace LLP raised its holdings in Herbalife by 2,053.6% in the 2nd quarter. Marshall Wace LLP now owns 1,977,155 shares of the company’s stock valued at $20,543,000 after acquiring an additional 1,885,346 shares in the last quarter.

About Herbalife

Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.